Featured Research

from universities, journals, and other organizations

New Horizons Of Nerve Repair: Biomedical Engineer Trips Up Proteins In Nerve Regeneration System

Date:
July 26, 2002
Source:
Washington University In St. Louis
Summary:
Shelly Sakiyama-Elbert, Ph.D., assistant professor of biomedical engineering at Washington University in St. Louis, has designed a system that employs a nerve guide tube filled with a gel containing growth factor proteins that stimulate nerve regeneration. Also part of the package are strategically placed sugars and peptides for binding in the gel matrix. The system has promoted peripheral nerve regeneration in preliminary rat studies.

It's sticky, it's a gel, it comes in a tube, but this is no greasy kids' stuff. Rather, it's a novel delivery system for peripheral nerve regeneration that could have implications for successful stem cell delivery and spinal cord repair.

Shelly Sakiyama-Elbert, Ph.D., assistant professor of biomedical engineering at Washington University in St. Louis, has designed a system that employs a nerve guide tube filled with a gel containing growth factor proteins that stimulate nerve regeneration. Also part of the package are strategically placed sugars and peptides for binding in the gel matrix. The system has promoted peripheral nerve regeneration in preliminary rat studies.

The clinical Gold Standard for peripheral nerve regeneration involves taking a nerve from a donor site on the injured person's body and sewing the donor nerve in between the two ends of the injured nerve. Though the nerve is dead, it provides a pathway that can guide the regeneration of the injured nerve. This is problematic because it creates an injury to be addressed at the donor site, and there is a limit to the amount of donor tissue you can use from a patient. Furthermore, there is no guarantee that the donated nerve will come to life in a new site. Another alternative is the use of cadaver nerves, which runs a risk of rejection.

Sakiyama-Elbert, working with famed plastic surgeon Susan Mackinnon ,M.D., Syd. M. and Robert H. Shoenberg Professor of Surgery of the Washington University Medical School, places exogenous sticky material capable of binding growth factors throughout the gel, causing the growth factor proteins to remain in the gel for months because they keep tripping over the sticky material. These binding sites can be tuned according to how fast the drug needs to be released for successful regeneration. Timed release is a key component of her system, because a real limitation is having the proteins diffuse out in a day or two, which is the case with many currently used systems.

Sakiyama-Elbert recently presented these results at a conference hosted by the Plastic Surgery Research Council, April 18-20, in Boston. Her work is sponsored by the Whitaker Foundation.

Another approach to peripheral nerve regeneration that Sakiyama-Elbert is testing involves creating her own protein consisting of a growth factor, and two different domains, a cross-linking site and a substrate for an enzyme that cleaves the growth factor at just the time a regenerating nerve cell would be migrating through the matrix. This cell-activated drug delivery system is also incorporated into a gel and delivered from a nerve guide tube, and it's a great example of a new area known as biologically responsible materials.

Stem cells for spinal cord repair

She also is one of very few researchers looking into matrixes for spinal cord damage, such as the kind that actor Christopher Reeves suffered years ago and from which he is not recovered. She is collaborating with John McDonald, M.D., Ph.D., assistant professor of neurobiology at the Washington University School of Medicine. McDonald already has treated spinal cord injuries in rats with embryonic stem cells; the problem is that most of the stem cells died after transplantation. Sakiyama-Elbert is hopeful that her matrix/tube delivery system will allow 50 to 75 percent survival of the stem cells by providing a more hospitable environment for the cells immediately after transplantation.

"The overall goal of this direction of my research is to apply novel bioengineering technology to allow controlled release of growth factors from scaffolds that facilitate the regeneration of adult spinal cord axons through and beyond spinal cord lesions," Sakiyama-Elbert said. "The scaffolds are drug-delivery systems consisting of protein matrices containing growth factors that are released in a sustained manner during tissue regeneration."

The scaffolds can be further modified by adding embryonic stem cells during polymerization, a process where small molecules are combined together to form larger ones.

"The embryonic stem cells can repopulate the injured spinal cord and serve as a source of nerve growth factors during regeneration," Sakiyama-Elbert explained.


Story Source:

The above story is based on materials provided by Washington University In St. Louis. Note: Materials may be edited for content and length.


Cite This Page:

Washington University In St. Louis. "New Horizons Of Nerve Repair: Biomedical Engineer Trips Up Proteins In Nerve Regeneration System." ScienceDaily. ScienceDaily, 26 July 2002. <www.sciencedaily.com/releases/2002/07/020725082253.htm>.
Washington University In St. Louis. (2002, July 26). New Horizons Of Nerve Repair: Biomedical Engineer Trips Up Proteins In Nerve Regeneration System. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/07/020725082253.htm
Washington University In St. Louis. "New Horizons Of Nerve Repair: Biomedical Engineer Trips Up Proteins In Nerve Regeneration System." ScienceDaily. www.sciencedaily.com/releases/2002/07/020725082253.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins